These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2154404)

  • 1. Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor.
    Sybertz EJ; Chiu PJ; Vemulapalli S; Watkins R; Haslanger MF
    Hypertension; 1990 Feb; 15(2):152-61. PubMed ID: 2154404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
    Sybertz EJ; Chiu PJ; Vemulapalli S; Pitts B; Foster CJ; Watkins RW; Barnett A; Haslanger MF
    J Pharmacol Exp Ther; 1989 Aug; 250(2):624-31. PubMed ID: 2547941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action.
    Sybertz EJ; Chiu PJ; Watkins RW; Vemulapalli S
    Can J Physiol Pharmacol; 1991 Oct; 69(10):1628-35. PubMed ID: 1838029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4-23) in Doca-salt hypertensive rats.
    Vemulapalli S; Chiu PJ; Brown A; Griscti K; Sybertz EJ
    Life Sci; 1991; 49(5):383-91. PubMed ID: 1649942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic factor potentiating and hemodynamic effects of SCH 42495, a new, neutral metalloendopeptidase inhibitor.
    Watkins RW; Vemulapalli S; Chiu PJ; Foster C; Smith EM; Neustadt B; Haslanger M; Sybertz EJ
    Am J Hypertens; 1993 May; 6(5 Pt 1):357-68. PubMed ID: 8512660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute and chronic blockade of neutral endopeptidase with Sch 34826 on NaCl-sensitive hypertension in spontaneously hypertensive rats.
    Jin H; Mathews C; Chen YF; Yang R; Wyss JM; Esunge P; Oparil S
    Am J Hypertens; 1992 Apr; 5(4 Pt 1):210-8. PubMed ID: 1318053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers.
    Burnier M; Ganslmayer M; Perret F; Porchet M; Kosoglou T; Gould A; Nussberger J; Waeber B; Brunner HR
    Clin Pharmacol Ther; 1991 Aug; 50(2):181-91. PubMed ID: 1831083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
    J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neutral endopeptidase inhibitor, SCH 34826, reduces left ventricular hypertrophy in spontaneously hypertensive rats.
    Monopoli A; Ongini E; Cigola E; Olivetti G
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):496-504. PubMed ID: 1279298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and humoral effects of chronic treatment with the neutral endopeptidase inhibitor SCH 42495 in spontaneously hypertensive rats.
    Sala C; Monopoli A; Casati C; Ardeleani G; Ongini E; Zanchetti A; Morganti A
    J Cardiovasc Pharmacol; 1994 May; 23(5):703-8. PubMed ID: 7521451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and hormonal effects of neutral endopeptidase inhibitor SCH 39370 in sheep.
    Charles CJ; Espiner EA; Cameron VA; Richards AM; Yandle TG; Sybertz EJ
    Hypertension; 1991 May; 17(5):643-51. PubMed ID: 1850715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutral endopeptidase inhibition attenuates development of hypoxic pulmonary hypertension in rats.
    Klinger JR; Petit RD; Warburton RR; Wrenn DS; Arnal F; Hill NS
    J Appl Physiol (1985); 1993 Oct; 75(4):1615-23. PubMed ID: 8282611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretory responses to renal nerve stimulation during inhibition of neutral metalloendopeptidase and angiotensin-converting enzyme in the rat.
    Golin R; Protasoni G; Wjinmaalen P; Sala C; Monopoli A; Casati C; Zanchetti A; Stella A
    J Cardiovasc Pharmacol; 1996 Nov; 28(5):665-71. PubMed ID: 8945680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCH 34826: an overview of its profile as a neutral endopeptidase inhibitor and ANF potentiator.
    Sybertz EJ
    Clin Nephrol; 1991 Oct; 36(4):187-91. PubMed ID: 1835684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent neutral endopeptidase and ACE inhibition in experimental heart failure: renal and hormonal effects.
    Helin K
    Scand J Clin Lab Invest; 1993 Dec; 53(8):843-51. PubMed ID: 8140395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats.
    Vemulapalli S; Watkins RW; Brown A; Cook J; Bernardino V; Chiu PJ
    Life Sci; 1993; 53(10):783-93. PubMed ID: 8355566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase.
    Seymour AA; Norman JA; Asaad MM; Fennell SA; Little DK; Kratunis VJ; Rogers WL
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):296-304. PubMed ID: 1709235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats.
    Seymour AA; Norman JA; Asaad MM; Fennell SA; Swerdel JN; Little DK; Dorso CR
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):163-72. PubMed ID: 1696660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072.
    Seymour AA; Fennell SA; Swerdel JN
    Hypertension; 1989 Jul; 14(1):87-97. PubMed ID: 2544529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.